TrialCancer communications (London, England)2025

First-line serplulimab plus chemotherapy in extensive-stage small-cell lung cancer: Updated results and biomarker analysis from the ASTRUM-005 randomized clinical trial.

Ying Cheng et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.